Search Results - "Beeley, Nigel R.A."

  • Showing 1 - 13 results of 13
Refine Results
  1. 1
  2. 2

    Can peptides be mimicked? by Beeley, Nigel R.A

    Published in Drug Discovery Today (01-08-2000)
    “…The biological activity of peptides is of enormous interest to the pharmaceutical industry, but endogenous peptides themselves typically have some limitations…”
    Get full text
    Book Review Journal Article
  3. 3

    6-LB: GPR119 Agonist PRM A Increases Glucagon Response to Hypoglycemia in Rats by KWOK, DAVID W.K., ALEXANDER, DIANE, BEELEY, NIGEL R.A., KELLEY, DAVID

    Published in Diabetes (New York, N.Y.) (20-06-2023)
    “…Glucagon (Gcg) is crucial in the counter-regulatory response (CRR) to hypoglycemia yet this is severely impaired in T1D. This pathophysiology was recognized 50…”
    Get full text
    Journal Article
  4. 4
  5. 5

    An in vivo model for screening peptidomimetic inhibitors of gelatinase A by Chander, S K, Antoniw, P, Beeley, N R, Boyce, B, Crabbe, T, Docherty, A J, Leonard, J, Mason, B, Millar, K, Millican, A T

    Published in Journal of pharmaceutical sciences (01-04-1995)
    “…Gelatinase A, a matrix metalloproteinase, is frequently associated with human solid tumors, and its secretion and activation in the tumor milieu is considered…”
    Get more information
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Corrigendum by Beeley, Nigel R.A.

    Published in Drug discovery today (01-10-2000)
    Get full text
    Journal Article
  10. 10

    GPCRs: an update on structural approaches to drug discovery by Beeley, Nigel R.A., Sage, Carleton

    Published in Targets (01-02-2003)
    “…G-protein-coupled receptors (GPCRs) are a major opportunity for drug discovery in the post-genomic era. There are thought to be more than 500 therapeutically…”
    Get full text
    Book Review Journal Article
  11. 11

    Improved tumor targeting with chemically cross-linked recombinant antibody fragments by KING, D. J, TURNER, A, MILLAR, K, MILLICAN, T. A, BOYCE, B. A, ANTONIW, P, MOUNTAIN, A, BEGENT, R. H. J, SHOCHAT, D, YARRANTON, G. T, FARNSWORTH, A. P. H, ADAIR, J. R, OWENS, R. J, PEDLEY, R. B, BALDOCK, D, PROUDFOOT, K. A, LAWSON, A. D. G, BEELEY, N. R. A

    Published in Cancer research (Chicago, Ill.) (01-12-1994)
    “…The construction and use of recombinant chimeric and later fully humanized (CDR-grafted) antibodies to tumor-associated antigens has reduced the immune…”
    Get full text
    Journal Article
  12. 12
  13. 13